Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council, highlights upcoming discussions on ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new ...
FROM nausea to constipation, we’ve all heard about the possible brutal side effects of fat jabs – but how familiar are you ...
Q4 2024 revenue increased 24.6% over Q3 2024; Full-year 2024 revenue grew 97.8% year-over-yearStrong growth in key commercial metrics, including ...
Digital Forensics Corporation is known for trying to help sextortion victims. But a USA TODAY investigation found complaints ...
Q4 2024 Earnings Call Transcript March 18, 2025 Operator: Greetings and welcome to the Acurx Pharmaceuticals Fourth Quarter ...
Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.
The government in Nigeria is warning about the health risks of skin lightening, where potent chemicals can thin and damage ...
The one thing holding Syria together now is Ahmed al-Sharaa, who has taken on the near-impossible job of teaching his people ...
With a fragile ceasefire in place, medics look to repair hospitals and care centres to get services running again ...